Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/fluorouracil/methotrexate/prednisone protocol

Known as: CTX/5-FU/MTX/PRED, CMFP protocol, CMFP 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMethotrexate
FluorouracilPrednisone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Budget-Constrained Maximum Flow Problem
  • 2016
  • Corpus ID: 13562915
An interesting application of Cmfp is for the case when the capacities of the arcs in the network are not fixed but can be… 
2004
2004
A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer
SummaryOne-hundred evaluable patients with progressive advanced breast carcinoma untreated by cytotoxic chemotherapy but… 
1996
1996
Animal performance and fleece characteristics of Angora goats maintained on western and southern Texas rangeland.
Two hundred castrated male Angora goats (18 mo of age) were divided equally between rangeland sites in the oak savannah of the… 
1992
1992
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Postoperative women with breast cancer but without histopathological evidence of metastases to the axillary lymph nodes or… 
1990
1990
Adjuvant chemotherapy and scar irradiation in breast cancer
Twenty‐three consecutive premenopausal patients with breast cancer who had four or more positive axillary nodes were treated with… 
1986
1986
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
1985
1985
Adjuvant treatment in operable breast cancer.
1984
1984
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Forty-one women with advanced breast cancer were treated with cyclophosphamide, methotrexate, 5-FU, and prednisone. Methotrexate… 
1982
1982
Prospects for Doxorubicin in Adjuvant Breast Cancer Trials
More than a decade ago, our medical oncology team initiated the first clinical studies on doxorubicin (1, 2) and, within the… 
1981
1981
Adriamycin, vincristine, dibromodulcitol, and hexamethylmelamine in advanced previously treated breast cancer: an ECOG pilot study.
A combination of adriamycin, vincristine, dibromodulcitol, and hexamethylmelamine was piloted in patients with advanced breast… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)